The fund’s investment objective is to provide capital growth through investment in UK and other companies. In order to achieve the objective the manager will invest in a focussed portfolio of securities. The emphasis of the fund will be investment in UK companies. The fund may also invest in companies headquartered or quoted outside the UK where those companies have material or critical operations within, or derive significant business from, the UK. Fixed interest securities may be included in the portfolio. Investment will be in directly held transferable securities. The fund may also invest in collective investment schemes, warrants and money market instruments.
Name | % Net Assets |
---|---|
Lloyds Banking Group | 5.2% |
Drax Group | 4.7% |
Debenhams | 4.1% |
Invensys | 4.1% |
GlaxoSmithKline | 3.7% |
Legal & General Group | 3.7% |
Intl Consolidated Airlines Group | 3.6% |
St James's Place | 3.5% |
Resolution | 3.5% |
Shire | 3.4% |
Key | % Net Assets |
---|---|
Lloyds Banking Group | 5.2% |
Drax Group | 4.7% |
Debenhams | 4.1% |
Invensys | 4.1% |
Other | 81.9% |
Date | 21-Nov-2024 |
---|---|
NAV | 233.90p |
Currency | GBP |
Change | -0.30p |
% | -0.13% |
YTD change | -2.40p |
YTD % | -1.02% |
Fund Inception | 24/06/2002 |
---|---|
Fund Manager | Alex Breese |
TER | 1.66 (31-May-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research